ALKERMES | ALKS - 現金と同等





現金と同等 変化する 日付
AbbVie USD 5.23B 400M 2025-12
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Amgen USD 9.13B 316M 2025-12
Biogen USD 3.38B 374.2M 2026-03
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Gilead Sciences USD 7.56B 234M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
J&J USD 21.69B 1.98B 2026-03
Malin Corporation EUR 62.1M 26.4M 2024-12
Merck USD 18.17B 10.16B 2025-09
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Otsuka Holdings JPY 534.64B 123.53B 2025-12
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12